Why Abzena?
Our focused approach.
Thomas Cornell gained his Ph.D. from Kings College London in the field of Chemical Biology. He then moved into the biotech startup space and spent almost a decade in preclinical vaccine research and development, focused on subunit vaccines.
Having worked on over 20 protein families, Tom has gained a wealth of protein engineering experience.
Tom joined Abzena 2 years ago and works within the protein engineering department working on pre-clinical development of Antibody drug candidates.
What is your biologic drug development challenge? Ask our expert today. We are ready to help.